Genetic Signatures Ltd
ASX:GSS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sinqia SA
BOVESPA:SQIA3
|
BR |
|
K
|
Kronox Lab Sciences Ltd
NSE:KRONOX
|
IN |
|
Jiangsu Expressway Co Ltd
HKEX:177
|
CN |
|
iEnergizer Ltd
LSE:IBPO
|
GG |
|
Doright Co Ltd
SZSE:300950
|
CN |
Genetic Signatures Ltd
Intangible Assets
Genetic Signatures Ltd
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Genetic Signatures Ltd
ASX:GSS
|
Intangible Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Genetic Technologies Ltd
ASX:GTG
|
Intangible Assets
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
Intangible Assets
AU$1k
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
T
|
Trajan Group Holdings Ltd
ASX:TRJ
|
Intangible Assets
AU$26.9m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
104%
|
CAGR 10-Years
N/A
|
|
|
Cryosite Ltd
ASX:CTE
|
Intangible Assets
AU$1.9m
|
CAGR 3-Years
470%
|
CAGR 5-Years
152%
|
CAGR 10-Years
16%
|
|
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
Intangible Assets
AU$28.1k
|
CAGR 3-Years
14%
|
CAGR 5-Years
88%
|
CAGR 10-Years
N/A
|
|
Genetic Signatures Ltd
Glance View
Genetic Signatures Ltd. engages in the research and commercialization of identifying individual genetic signatures to identify diseases and disabilities. The company is headquartered in Sydney, New South Wales. The company went IPO on 2015-03-31. The firm is engaged in research and commercialization of identifying individual genetic signatures to aid in the diagnosis of infectious diseases and the sale of associated products into the diagnostic and research marketplaces. The firm is focused on the development and commercialization of its platform technology, 3Base. The Company’s 3Base platform technology provides hospital and pathology laboratories the ability to screen for an array of infectious pathogens, with a degree of specificity, in a rapid throughput (time-to-result) environment. The company also manufactures a Polymerase Chain Reaction (PCR) based products for the detection of infectious diseases under the EasyScreen brand. The Company’s EasyScreen sample processing kits are used to perform 3Base conversion and nucleic acid extraction and purification.
